Natural Products and LncRNAs in Non-Small Cell Lung Cancer: Emerging Therapeutic Approaches

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality globally, often due to late diagnosis, metastasis, and treatment resistance.
• Long non-coding RNAs (lncRNAs) play a critical role in NSCLC progression by influencing cell proliferation, apoptosis, epithelial-mesenchymal transition (EMT), and drug resistance.
• Natural products are emerging as potential anticancer agents, particularly in targeting signaling pathways involved in tumorigenesis and drug resistance.

Purpose of the Study:

• To analyze the role of lncRNAs in NSCLC tumorigenesis, metastasis, and therapeutic resistance.
• To explore the potential of natural products in modulating lncRNA expression for NSCLC treatment.
• To identify novel therapeutic strategies and biomarkers by understanding the interaction between lncRNAs and natural products.

Main Methods:

• Literature review and analysis of existing research on lncRNAs in NSCLC.
• Examination of studies on natural products (e.g., curcumin, resveratrol, epigallocatechin gallate) and their effects on lncRNA expression.
• Synthesis of information on the molecular mechanisms underlying lncRNA modulation by natural products.

Main Results:

• lncRNAs significantly contribute to NSCLC development, metastasis, and resistance to chemotherapy.
• Natural products can regulate both oncogenic and tumor-suppressive lncRNAs, inhibiting metastasis and reversing chemoresistance.
• Specific compounds like curcumin, resveratrol, and epigallocatechin gallate demonstrate efficacy in modulating lncRNAs.

Conclusions:

• lncRNAs are crucial etiological factors in NSCLC progression and therapeutic failure.
• Natural products offer a promising avenue for NSCLC treatment by modulating lncRNA expression.
• Further research into the lncRNA-natural product axis may reveal novel biomarkers and therapeutic strategies for NSCLC.